Amgen(AMGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AMGN Amgen

Post-Mkt 04-24 17:16:55 EDT

344.55

-4.07

-1.17%

盘后346.48

+1.93+0.56%

17:16 EDT

High347.66	Low342.52	Vol2.19M
Open346.00	D1 Closing348.62	Amplitude1.47%
Mkt Cap185.53B	Tradable Cap185.02B	Total Shares538.48M
T/O758.01M	T/O Rate0.41%	Tradable Shares536.99M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"AMGN","market":"US","secType":"STK","nameCN":"Amgen","latestPrice":344.55,"timestamp":1777060800000,"preClose":348.62,"halted":0,"volume":2194343,"hourTrading":{"tag":"盘后","latestPrice":346.4802,"preClose":344.55,"latestTime":"17:16 EDT","volume":74264,"amount":25587687.192399997,"timestamp":1777065407357,"change":1.9302,"changeRate":0.005602,"amplitude":0.009723},"delay":0,"changeRate":-0.011674602719293194,"floatShares":536994627,"shares":538480671,"eps":14.23,"marketStatus":"Post-Mkt","change":-4.07,"latestTime":"04-24 17:16:55 EDT","open":346,"high":347.66,"low":342.52,"amount":758006209.60636,"amplitude":0.014744,"askPrice":348,"askSize":100,"bidPrice":343,"bidSize":2,"shortable":3,"etf":0,"ttmEps":14.23,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1777075200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":423288000000,"exchange":"NASDAQ","adjPreClose":348.62,"dividendRate":0.028037,"preHourTrading":{"tag":"盘前","latestPrice":346.01,"preClose":348.62,"latestTime":"09:29 EDT","volume":10170,"amount":3519027.468,"timestamp":1777037399999,"change":-2.61,"changeRate":-0.007487,"amplitude":0.015375},"postHourTrading":{"tag":"盘后","latestPrice":346.4802,"preClose":344.55,"latestTime":"17:16 EDT","volume":74264,"amount":25587687.192399997,"timestamp":1777065407357,"change":1.9302,"changeRate":0.005602,"amplitude":0.009723},"volumeRatio":0.911994,"impliedVol":0.3376,"impliedVolPercentile":0.8845},"requestUrl":"/m/hq/s/AMGN/tweets","defaultTab":"tweets","newsList":[{"id":"1160663333","title":"Earning Preview: Amgen this quarter’s revenue is expected to increase by 6.60%, and institutional views are predominantly bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1160663333","media":"Earnings Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1160663333?lang=en_us&edition=fundamental","pubTime":"2026-04-24 01:08","pubTimestamp":1776964139,"startTime":"0","endTime":"0","summary":"Abstract Amgen will report its quarterly results on April 30, 2026 Post Market; investors are watching revenue growth, margin resilience after integration costs, and pipeline catalysts that could...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: Amgen this quarter’s revenue is expected to increase by 6.60%, and institutional views are predominantly bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630822443","title":"Amgen to report first-quarter results after US market close, host conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2630822443","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630822443?lang=en_us&edition=fundamental","pubTime":"2026-04-25 04:01","pubTimestamp":1777060879,"startTime":"0","endTime":"0","summary":"Amgen will release first-quarter 2026 financial results on April 30, 2026.Conference call set for April 30, 2026 at 4:30 p.m. ET.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDL96Bx1r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","BK4139","LU2089984988.USD","LU2242652126.USD","IE00BFTCPJ56.SGD","BK4533","LU0289739699.SGD","LU2112291526.USD","IE0009355771.USD","BK4585","LU0320765992.SGD","LU1983299246.USD","LU2242646821.SGD","LU1571399168.USD","LU1023059063.AUD","LU1061106388.HKD","AMGN","IE00BJJMRZ35.SGD","BK4588","BK4534","LU0109394709.USD","SG9999001440.SGD","BK4599","LU0122379950.USD","IE00BJT1NW94.SGD","LU0868494617.USD","LU1057294990.SGD","LU2468319806.SGD","IE00B2B36J28.USD","LU0058720904.USD","IE0002141913.USD","BK4581","IE00B4R5TH58.HKD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629848024","title":"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Medpace Holdings (MEDP) and Ultragenyx Pharmaceutical (RARE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629848024","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629848024?lang=en_us&edition=fundamental","pubTime":"2026-04-24 19:00","pubTimestamp":1777028420,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amgen (AMGN), Medpace Holdings (MEDP) and Ultragenyx...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-medpace-holdings-medp-and-ultragenyx-pharmaceutical-rare-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-medpace-holdings-medp-and-ultragenyx-pharmaceutical-rare-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0868494617.USD","RARE","XBI","SG9999001440.SGD","LU0128526141.USD","LU0029874061.USD","BK4581","LU0289739699.SGD","LU1057294990.SGD","BK4137","IE00B2B36J28.USD","IE00BJT1NW94.SGD","XLV","IE00B4R5TH58.HKD","BK4585","LU1571399168.USD","LU1061106388.HKD","BK4566","LU1983299246.USD","LU2089984988.USD","BK4139","MEDP","HCSG","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","AMGN","IE0002141913.USD","LU1023059063.AUD","BK4533","LU2065169927.USD","LU2065170008.USD","LU2065171311.SGD","LU2242646821.SGD","LU2065171402.SGD","IE0009355771.USD","LABU","BK4534","LU2242652126.USD","LU0109394709.USD","BK4121","BK4588","LU2112291526.USD","LU0320765992.SGD","LU2468319806.SGD","BK4599","LU0058720904.USD","LU0889565916.HKD","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629859703","title":"Amgen Marks Key Milestone With Completion of Early MTAP-Null Cancer Combo Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2629859703","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629859703?lang=en_us&edition=fundamental","pubTime":"2026-04-24 00:31","pubTimestamp":1776961872,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) has completed a Phase 1/2 study titled “A Phase 1/2 Study ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgen-marks-key-milestone-with-completion-of-early-mtap-null-cancer-combo-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgen-marks-key-milestone-with-completion-of-early-mtap-null-cancer-combo-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BJJMRZ35.SGD","LU0868494617.USD","LU1057294990.SGD","BK4534","LU1023059063.AUD","BK4585","LU1983299246.USD","BK4533","LU2242646821.SGD","BK4599","LU0320765992.SGD","LU0889565916.HKD","LU2089984988.USD","LU2112291526.USD","LU2242652126.USD","LU0122379950.USD","IE00BJT1NW94.SGD","LU1571399168.USD","IE00B4R5TH58.HKD","LU0289739699.SGD","SG9999001440.SGD","BK4139","BK4588","IE0009355771.USD","IE00BFTCPJ56.SGD","LU0058720904.USD","IE0002141913.USD","AMGN","LU1061106388.HKD","IE00B2B36J28.USD","LU0109394709.USD","BK4581","BK4566","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629073452","title":"Amgen Announces CTO Retirement and Strategic Leadership Realignment","url":"https://stock-news.laohu8.com/highlight/detail?id=2629073452","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629073452?lang=en_us&edition=fundamental","pubTime":"2026-04-23 04:51","pubTimestamp":1776891063,"startTime":"0","endTime":"0","summary":"Amgen ( ($AMGN) ) has issued an update. On April 22, 2026, Amgen announced that David M. Reese, M.D., executive vice president and chief technology...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgen-announces-cto-retirement-and-strategic-leadership-realignment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgen-announces-cto-retirement-and-strategic-leadership-realignment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1023059063.AUD","BK4160","BK4533","LU0109394709.USD","LU2468319806.SGD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","BK4566","CTO","IE00B2B36J28.USD","LU1066051498.USD","LU1066051225.USD","LU0889565916.HKD","LU0289739699.SGD","LU2112291526.USD","BK4534","LU2242652126.USD","LU0320765992.SGD","BK4599","BK4581","LU1571399168.USD","LU1066053197.SGD","SG9999001440.SGD","BK4585","LU2242646821.SGD","IE0002141913.USD","LU1066051811.HKD","LU1983299246.USD","LU0868494617.USD","LU1057294990.SGD","AMGN","IE00BJT1NW94.SGD","LU0122379950.USD","BK4139","IE00BFTCPJ56.SGD","LU1061106388.HKD","LU0058720904.USD","LU2089984988.USD","BK4588","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629027563","title":"Amgen names Sean Bruich chief technology officer as David Reese retires","url":"https://stock-news.laohu8.com/highlight/detail?id=2629027563","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629027563?lang=en_us&edition=fundamental","pubTime":"2026-04-23 04:00","pubTimestamp":1776888046,"startTime":"0","endTime":"0","summary":"Amgen set retirement of Executive Vice President, Chief Technology Officer David M. Reese effective June 30, 2026.Management changes effective June 1, 2026 shift James Bradner to Executive Vice President, Research and Development, Artificial Intelligence and Data; he is a physician-scientist focused on biology-technology integration.Sean Bruich named Senior Vice President, Chief Technology Officer; he has led Amgen AI and data capability buildout across technology and data science.Murdo Gordon moved to Executive Vice President, Amgen Global Markets and Policy, covering medical, commercial operations, government affairs and policy; he has led global markets and policy work with health systems and clinicians.Paul Burton continues as Senior Vice President, Chief Medical Officer, maintaining focus on clinician and patient engagement across priority disease areas.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL6KrJP5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU1061106388.HKD","LU1983299246.USD","LU1023059063.AUD","LU1057294990.SGD","LU2468319806.SGD","BK4139","BK4534","SG9999001440.SGD","IE00B2B36J28.USD","IE0002141913.USD","LU0058720904.USD","IE0009355771.USD","BK4588","AMGN","LU0289739699.SGD","IE00BJJMRZ35.SGD","LU0122379950.USD","LU2242652126.USD","BK4599","LU2242646821.SGD","LU0889565916.HKD","IE00B4R5TH58.HKD","BK4533","LU0868494617.USD","BK4585","LU0109394709.USD","LU2089984988.USD","LU0320765992.SGD","LU1571399168.USD","LU2112291526.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629273770","title":"Amgen Announces Retirement of David M. Reese, Executive Vice President and Chief Technology Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2629273770","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629273770?lang=en_us&edition=fundamental","pubTime":"2026-04-23 04:00","pubTimestamp":1776888000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nTUA333JV3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0002141913.USD","LU0058720904.USD","BK4585","BK4599","IE00BJJMRZ35.SGD","LU1571399168.USD","BK4139","LU1023059063.AUD","AMGN","BK4581","IE0009355771.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0320765992.SGD","BK4588","LU1983299246.USD","LU2089984988.USD","IE00B2B36J28.USD","BK4533","LU2468319806.SGD","LU0289739699.SGD","LU2112291526.USD","LU1061106388.HKD","IE00BJT1NW94.SGD","BK4566","LU0122379950.USD","BK4534","LU1057294990.SGD","SG9999001440.SGD","LU0868494617.USD","LU2242646821.SGD","LU2242652126.USD","LU0109394709.USD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629027910","title":"Press Release: AMGEN ANNOUNCES RETIREMENT OF DAVID M. REESE, EXECUTIVE VICE PRESIDENT AND CHIEF TECHNOLOGY OFFICER","url":"https://stock-news.laohu8.com/highlight/detail?id=2629027910","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629027910?lang=en_us&edition=fundamental","pubTime":"2026-04-23 04:00","pubTimestamp":1776888000,"startTime":"0","endTime":"0","summary":"Organizational Changes Further Emphasize Integration of Biology and Technology. THOUSAND OAKS, Calif., April 22, 2026 /PRNewswire/ -- Amgen  today announced the retirement of David M. Reese, M.D., executive vice president and Chief Technology Officer, effective June 30, 2026.Reese joined Amgen in 2005 as a clinical development leader in oncology and later served as executive vice president of Research and Development (R&D) from 2018 to 2023. During his tenure, he led approvals of numerous innovative medicines and biosimilars, advanced a robust pipeline of potential new therapies and strengthened discovery research capabilities. As inaugural chief technology officer, Reese encouraged the early adoption of technology and artificial intelligence across all facets of the business, in particular R&D.\"Dave recognized early the impact that advances in biology and technology would have on our industry and helped lead Amgen through that shift,\" said Robert A. Bradway, chairman and chief executi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU0868494617.USD","LU0289739699.SGD","LU1023059063.AUD","LU0122379950.USD","IE00B2B36J28.USD","BK4581","BK4588","LU1983299246.USD","LU1057294990.SGD","LU1571399168.USD","LU2468319806.SGD","BK4139","SG9999001440.SGD","BK4566","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0889565916.HKD","IE0002141913.USD","LU2089984988.USD","BK4585","AMGN","LU0109394709.USD","LU2242646821.SGD","IE00BJJMRZ35.SGD","LU2242652126.USD","BK4022","LU1061106388.HKD","BK4232","BK4533","LU2112291526.USD","IE0009355771.USD","VICE","R","LU0058720904.USD","BK4599","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629302464","title":"The next time your health insurance denies a medication or procedure, here's how to appeal it. You'll probably win.","url":"https://stock-news.laohu8.com/highlight/detail?id=2629302464","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629302464?lang=en_us&edition=fundamental","pubTime":"2026-04-23 02:40","pubTimestamp":1776883200,"startTime":"0","endTime":"0","summary":"Your insurer is betting you won't appeal - but research shows 1 million denials could have been overturned if patients pushed back. In an analysis of six Medicare Advantage plans covering more than 23 million members, there were more than 1.9 million denials. Of the 7% who appealed, 66% got their appeals overturned.In my analysis of six Medicare Advantage plans covering more than 23 million members, there were more than 1.9 million denials, about 10%. Only 7% appealed their denials, but for those who did, 66% of those appeals were overturned.In most industries, a high defect rate is a problem to fix because it wastes time and money. Imagine if your credit card company declined every tenth transaction, reviewed and approved them only if you called, and then determined that more than half of the charges were not fraudulent at all.In most industries, a 66% defect rate would trigger an immediate focus on process improvement. In health insurance, that doesn't happen. The financial incent","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","LABU","LU0320765992.SGD","LU2089984988.USD","BK4599","LU2468319806.SGD","BK4588","BK4534","LU1571399168.USD","LU0868494617.USD","IE0002141913.USD","SG9999001440.SGD","IE00BFTCPJ56.SGD","LU2242646821.SGD","IE0009355771.USD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","BK4566","LU0289739699.SGD","AMGN","LU0889565916.HKD","LU1023059063.AUD","BK4581","BK4533","LU1061106388.HKD","BK4585","LU2112291526.USD","XLV","LU2242652126.USD","IE00BJJMRZ35.SGD","LU0058720904.USD","IE00BJT1NW94.SGD","LU0109394709.USD","BK4139","LU1983299246.USD","LU0122379950.USD","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629501642","title":"Amgen (AMGN) Initiated with a Hold at Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2629501642","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629501642?lang=en_us&edition=fundamental","pubTime":"2026-04-22 16:53","pubTimestamp":1776847998,"startTime":"0","endTime":"0","summary":"Canaccord Genuity analyst initiated coverage with a Hold rating on Amgen yesterday and set a price target of $366.00. The company’s shares closed y...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/amgen-amgn-initiated-with-a-hold-at-canaccord-genuity-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/amgen-amgn-initiated-with-a-hold-at-canaccord-genuity-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BJJMRZ35.SGD","LU0868494617.USD","LU1057294990.SGD","BK4534","LU1023059063.AUD","BK4585","LU1983299246.USD","BK4533","LU2242646821.SGD","BK4599","LU0320765992.SGD","LU0889565916.HKD","LU2089984988.USD","LU2112291526.USD","LU2242652126.USD","LU0122379950.USD","IE00BJT1NW94.SGD","LU1571399168.USD","IE00B4R5TH58.HKD","LU0289739699.SGD","SG9999001440.SGD","BK4139","BK4588","IE0009355771.USD","IE00BFTCPJ56.SGD","LU0058720904.USD","IE0002141913.USD","AMGN","LU1061106388.HKD","IE00B2B36J28.USD","LU0109394709.USD","BK4581","BK4566","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629505567","title":"Amgen Initiated at Hold by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2629505567","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629505567?lang=en_us&edition=fundamental","pubTime":"2026-04-21 23:45","pubTimestamp":1776786300,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AMGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 21, 2026 11:45 ET (15:45 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU1061106388.HKD","LU1983299246.USD","LU1023059063.AUD","LU1057294990.SGD","LU2468319806.SGD","BK4139","BK4534","SG9999001440.SGD","IE00B2B36J28.USD","IE0002141913.USD","LU0058720904.USD","IE0009355771.USD","BK4588","AMGN","LU0289739699.SGD","IE00BJJMRZ35.SGD","LU0122379950.USD","LU2242652126.USD","BK4599","LU2242646821.SGD","LU0889565916.HKD","IE00B4R5TH58.HKD","BK4533","LU0868494617.USD","BK4585","LU0109394709.USD","LU2089984988.USD","LU0320765992.SGD","LU1571399168.USD","LU2112291526.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629031663","title":"Amgen (AMGN) Receives a Hold from Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2629031663","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629031663?lang=en_us&edition=fundamental","pubTime":"2026-04-21 20:38","pubTimestamp":1776775106,"startTime":"0","endTime":"0","summary":"Bernstein analyst Courtney Breen maintained a Hold rating on Amgen today and set a price target of $335.00. Breen covers the Healthcare sector, foc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/amgen-amgn-receives-a-hold-from-bernstein-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/amgen-amgn-receives-a-hold-from-bernstein-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2242646821.SGD","XLV","BK4534","LU0320765992.SGD","LU1061106388.HKD","LU1983299246.USD","LABU","LU0058720904.USD","BK4588","BK4533","IE00BJT1NW94.SGD","SG9999001440.SGD","LU2468319806.SGD","BK4566","LU0109394709.USD","LU2089984988.USD","IE0002141913.USD","BK4599","LU2242652126.USD","LU2112291526.USD","AMGN","BK4585","BK4139","XBI","IE0009355771.USD","IE00BJJMRZ35.SGD","LU0868494617.USD","LU0289739699.SGD","BK4581","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU1571399168.USD","IE00B2B36J28.USD","LU1057294990.SGD","LU0122379950.USD","LU1023059063.AUD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629849980","title":"Canaccord Genuity Initiates Amgen at Hold With $366 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2629849980","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629849980?lang=en_us&edition=fundamental","pubTime":"2026-04-21 17:28","pubTimestamp":1776763738,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) has an average rating of overweight and mean price target of $357.77, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629081847","title":"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Brookdale Senior Living (BKD) and 10x Genomics (TXG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629081847","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629081847?lang=en_us&edition=fundamental","pubTime":"2026-04-21 17:01","pubTimestamp":1776762067,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN), Brookdale Senior Living (BKD) and 10...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-brookdale-senior-living-bkd-and-10x-genomics-txg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-brookdale-senior-living-bkd-and-10x-genomics-txg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BJJMRZ35.SGD","LU1861558580.USD","BK4121","BK4185","XLV","LU0109394709.USD","LU2089984988.USD","LU2242646821.SGD","IE00B2B36J28.USD","LABU","IE0009355771.USD","LU0029874061.USD","BK4585","LU2190626999.HKD","BK4599","LU0122379950.USD","IE00B4R5TH58.HKD","LU1023059063.AUD","BK4548","LU0320765992.SGD","BK4581","BK4137","BK4566","IE00BFTCPJ56.SGD","LU0128526141.USD","BK4588","LU0289739699.SGD","LU1061106388.HKD","LU2242652126.USD","LU2112291526.USD","LU0842063009.USD","BKD","LU1499592464.USD","IE00BJT1NW94.SGD","BK4533","IE0002141913.USD","BK4139","BK4534","LU1057294990.SGD","HCSG","LU0868494617.USD","LU1571399168.USD","SG9999001440.SGD","XBI","AMGN","TXG","LU2468319806.SGD","LU0058720904.USD","LU0889565916.HKD","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629776480","title":"Amgen Inc. Stock Outperforms Competitors Despite Losses On The Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2629776480","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629776480?lang=en_us&edition=fundamental","pubTime":"2026-04-21 04:35","pubTimestamp":1776717300,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  slid 1.45% to $350.16 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.24% to 7,109.14 and Dow Jones Industrial Average  falling 0.01% to 49,442.56.The stock's fall snapped a two-day winning streak.Amgen Inc. closed 10.51% short of its 52-week high of $391.29, which the company achieved on March 2nd.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson  fell 1.49% to $230.69, Pfizer Inc.  fell 0.15% to $27.52, and AbbVie Inc.  fell 2.24% to $203.71.Trading volume  remained 662,531 below its 50-day average volume of 2.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled April 20, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2430703178.SGD","LU0234572021.USD","BK4139","LU1093756325.SGD","LU1061106388.HKD","IE0001KFT4U8.USD","IE000M9KFDE8.USD","LU0211327993.USD","LU0321505868.SGD","LU2750360641.GBP","LU1989772923.USD","LU1989771016.USD","LU1267930573.SGD","SG9999002224.SGD","BK4581","LU2237443549.SGD","IE00BVYPNV92.GBP","LU0820561909.HKD","IE00B1BXHZ80.USD","LU0058720904.USD","LU2237443382.USD","SG9999001176.SGD","LU0417517546.SGD","ABBV","IE00BJT1NW94.SGD","LU1929549753.HKD","LU1934455277.USD","LU0965508806.USD","LU0912757837.SGD","LU1121112475.USD","LU1032955483.USD","LU1037948897.HKD","LU1043141396.HKD","LU1674673691.USD","LU0545039389.USD","LU1003077747.HKD","IE00B7SZLL34.SGD","LU2089984988.USD","LU2602419157.SGD","LU0345770993.USD","IE00BJJMRZ35.SGD","LU0310799852.SGD","LU2129689514.USD","LU0057025933.USD","SG9999011175.SGD","LU2471134796.USD","LU0456855351.SGD","BK4568","BK4566","IE00BFXG1179.USD","IE00BKVL7J92.USD","LU0069063385.USD","LU1221951046.USD","LU1267930813.SGD","LU2089283258.USD","LU1496350171.SGD","LU2347655156.SGD","BK4599","LU0965509283.SGD","LU2133065610.SGD","BK4588","IE00BZ1G4Q59.USD","LU1267930490.SGD","LU2112291526.USD","04332","IE0002141913.USD","LU0122379950.USD","LU0198837287.USD","LU1074936037.SGD","LU2505996681.GBP","LU2471134523.USD","LU0965509010.AUD","LU0211328371.USD","PFE","IE00BLSP4452.SGD","LU1894683348.USD","IE00B19Z3B42.SGD","LU0868494708.USD","LU1496350502.SGD","IE000BZT7R73.USD","IE000WAW04H5.SGD","LU0114720955.EUR","IE00BN8TJ469.HKD","IE00BVYPNW00.USD","LU0868494617.USD","LU0985481810.HKD","LU1059921491.USD","LU1032466523.USD","LU1221951129.SGD","LU0321505439.SGD","IE0002270589.USD","LU0053666078.USD","LU0823416689.USD","LU0965509101.SGD","LU1585245621.USD","LU1093756168.USD","IE0009355771.USD","LU1718418525.SGD","LU1551013425.SGD","IE00BGHQF631.EUR","LU2089284900.SGD","LU1934455194.USD","IE00BBT3K403.USD","LU2430703095.HKD","IE00BFTCPJ56.SGD","SG9999015945.SGD","LU2357627491.SGD","IE000F7OJYX1.SGD","LU0738911758.USD","LU0320765992.SGD","BK4585","LU0225284248.USD","LU0661504455.SGD","LU1989772840.SGD","LU0310800379.SGD","IE00BLSP4239.USD","LU0128525929.USD","LU1066053197.SGD","LU1894683264.USD","LU1162221912.USD","LU1291159041.SGD","IE00B4R5TH58.HKD","IE00BSNM7G36.USD","LU0859254822.USD","LU1732800096.USD","LU0466842654.USD","IE00B3PB1722.GBP","LU2750360997.AUD","SG9999015986.USD","LU0426412945.USD","LU2471134952.CNY","IE000SO60NU8.SGD","LU0787776722.HKD","LU1244550221.USD","LU2237443622.USD","LU0210536198.USD","LU0210528500.USD","LU0792757196.USD","LU1571399168.USD","LU0949170772.SGD","LU1037948541.HKD","LU0289961442.SGD","LU0109394709.USD","LU0345769631.USD","BK4559","LU0289739699.SGD","LU0683600562.USD","LU1732799900.SGD","SG9999015978.USD","LU0511384066.AUD","LU1506573853.SGD","LU0426417589.USD","IE0034235303.USD","LU1244550577.SGD","IE00B3T34201.USD","LU0289739343.SGD","LU0432979614.USD","LU1934455863.HKD","LU2129689431.USD","LU2237443465.HKD","IE0004445239.USD","AMGN","LU0256863811.USD","LU2430703251.USD","JNJ","LU1914381329.SGD","IE000MB6IJN5.SGD","IE00B2B36J28.USD","BK4533","IE00B19Z3581.USD","LU0256863902.USD","LU0942090050.USD","LU1839511570.USD","LU2468319806.SGD","LU0553294199.USD","LU0994945656.USD","LU2505996509.AUD","LU0098860793.USD","BK4532","LU0689626769.HKD","LU1066051498.USD","LU2487616109.SGD","BK4007","LU1261432733.SGD","BK4504","IE0000B7K699.USD","LU0889566641.SGD","LU0985320562.USD","LU0029864427.USD","SG9999001440.SGD","LU2023251221.USD","LU0795875086.SGD","LU0124676726.USD","LU1066051225.USD","BK4550","SG9999003800.SGD","SGXZ57979304.SGD","SG9999015952.SGD","LU0225771236.USD","LU2471134879.HKD","LU0943347566.SGD","LU0689472784.USD","BK4534","LU1935042991.SGD","LU2592432038.USD","LU0640476718.USD","LU1244550494.USD","LU0820561818.USD","SG9999002232.USD","LU0170899867.USD","LU1280957306.USD","LU1674673428.USD","LU0861579265.USD","BK4592","LU0203345920.USD","LU0306807586.USD","LU0234570918.USD","LU0345769128.USD","IE00BDGV0183.EUR","IE00B42XCP33.USD","LU0708994859.HKD","LU0345770308.USD","LU0889565916.HKD","LU1551013342.USD","LU2087621335.USD","LU1043141123.HKD","LU1066051811.HKD","LU2237443978.SGD","LU2129689605.HKD","LU2242646821.SGD","LU1057294990.SGD","LU2237443895.HKD","LU2242652126.USD","LU1196500208.SGD","LU1023059063.AUD","LU0472753341.HKD","LU2896262040.SGD","LU0320765646.SGD","LU0070217475.USD","LU1430594728.SGD","LU0882574055.USD","LU1778281490.HKD","LU1883839398.USD","LU0203347892.USD","LU0306806265.USD","SG9999013999.USD","LU0795875169.SGD","LU1983299246.USD","SG9999001176.USD","LU0158827948.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629776371","title":"Amgen initiated with a Hold at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2629776371","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629776371?lang=en_us&edition=fundamental","pubTime":"2026-04-21 04:15","pubTimestamp":1776716151,"startTime":"0","endTime":"0","summary":"Canaccord initiated coverage of Amgen (AMGN) with a Hold rating and $366 price target Published first on TheFly – the ultimate source for real-time...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-initiated-with-a-hold-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-initiated-with-a-hold-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LU0320765992.SGD","LU0058720904.USD","BK4139","LU1023059063.AUD","LU2242652126.USD","IE0009355771.USD","BK4534","BK4585","IE00BJJMRZ35.SGD","LU2089984988.USD","LU0289739699.SGD","IE00BFTCPJ56.SGD","SG9999001440.SGD","LU0868494617.USD","LU1061106388.HKD","IE0002141913.USD","IE00B4R5TH58.HKD","LU1983299246.USD","BK4533","IE00B2B36J28.USD","LU1057294990.SGD","LU2242646821.SGD","LU1571399168.USD","BK4566","BK4588","AMGN","LU0122379950.USD","LU0109394709.USD","LU2468319806.SGD","LU2112291526.USD","IE00BJT1NW94.SGD","BK4599","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628459257","title":"Market Chatter: Pfizer, Amgen Eyeing Hong Kong Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2628459257","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628459257?lang=en_us&edition=fundamental","pubTime":"2026-04-20 17:12","pubTimestamp":1776676368,"startTime":"0","endTime":"0","summary":"Pfizer  and Amgen  are among 22 strategic firms looking to expand in Hong Kong under the sixth batch of the government's flagship investment-attraction program, the South China Morning Post reported Monday, citing an unnamed source.The two companies are expected to sign deals with the Office for Attracting Strategic Enterprises, the paper said.Pfizer and Amgen did not immediately respond to MT Newswires' requests for comment.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4550","LU0321505439.SGD","LU1066051498.USD","LU2468319806.SGD","SG9999003800.SGD","LU0109394709.USD","LU0889565916.HKD","SG9999001176.SGD","LU1983299246.USD","LU0868494617.USD","LU2089984988.USD","BK4007","SG9999001176.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","BK4139","LU0225284248.USD","LU0234572021.USD","LU2242646821.SGD","IE0002141913.USD","BK4592","BK4534","IE00BJJMRZ35.SGD","LU0170899867.USD","LU0306807586.USD","IE0002270589.USD","LU1894683264.USD","SG9999011175.SGD","LU1883839398.USD","IE00B19Z3B42.SGD","LU1061106388.HKD","LU1066053197.SGD","BK4568","LU0289739699.SGD","LU1571399168.USD","LU1894683348.USD","IE00BLSP4452.SGD","LU2242652126.USD","SG9999002224.SGD","SG9999002232.USD","SGXZ57979304.SGD","LU0985481810.HKD","IE000M9KFDE8.USD","LU0321505868.SGD","BK4566","04332","LU0122379950.USD","LU0456855351.SGD","BK4581","LU0320765992.SGD","LU0225771236.USD","BK4588","LU1023059063.AUD","BK4585","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE00BLSP4239.USD","AMGN","BK4533","IE0009355771.USD","LU0058720904.USD","LU1057294990.SGD","PFE","LU2112291526.USD","IE00B19Z3581.USD","BK7095","IE00BBT3K403.USD","SG9999001440.SGD","BK4599","SG9999013999.USD","LU0306806265.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628623947","title":"Will Amgen’s Subcutaneous Tepezza Success Reshape Viridian Therapeutics' (VRDN) Thyroid Eye Disease Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2628623947","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628623947?lang=en_us&edition=fundamental","pubTime":"2026-04-19 17:06","pubTimestamp":1776589616,"startTime":"0","endTime":"0","summary":"In recent days, Viridian Therapeutics has come under renewed attention after Amgen reported positive Phase 3 results for a subcutaneous version of Tepezza in moderate to severe active thyroid eye disease, raising questions about future treatment options in this space.\nThis competing clinical success places a spotlight on how Viridian’s own thyroid eye disease pipeline could fit into an evolving treatment landscape and patient preference profile.\nNext, we’ll examine how Amgen’s subcutaneous...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrdn/viridian-therapeutics/news/will-amgens-subcutaneous-tepezza-success-reshape-viridian-th","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrdn/viridian-therapeutics/news/will-amgens-subcutaneous-tepezza-success-reshape-viridian-th","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4599","IE00B4R5TH58.HKD","BK4139","BK4588","LU2112291526.USD","LU1061106388.HKD","IE0002141913.USD","LU0122379950.USD","BK4581","BK4534","LU1571399168.USD","LU0109394709.USD","LU0058720904.USD","VRDN","LU0289739699.SGD","LU0868494617.USD","IE00BJT1NW94.SGD","IE0009355771.USD","AMGN","LU0889565916.HKD","LU2242646821.SGD","LU2089984988.USD","IE00BFTCPJ56.SGD","LU1057294990.SGD","LU2242652126.USD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4533","LU1023059063.AUD","LU2468319806.SGD","LU0320765992.SGD","BK4585","BK4566","LU1983299246.USD","SG9999001440.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628676376","title":"Is It Too Late To Consider Amgen (AMGN) After A 32% One-Year Share Price Rally?","url":"https://stock-news.laohu8.com/highlight/detail?id=2628676376","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628676376?lang=en_us&edition=fundamental","pubTime":"2026-04-19 13:05","pubTimestamp":1776575124,"startTime":"0","endTime":"0","summary":"If you are wondering whether Amgen’s share price still offers value after a strong run, this breakdown will help you weigh what you are really paying for.\nAt a last close of US$355.30, the stock has returned 1.2% over 7 days, 2.2% over 30 days, 8.4% year to date, 32.2% over 1 year, 60.1% over 3 years, and 61.7% over 5 years. These figures raise fair questions about what is already reflected in the price.\nRecent attention around Amgen has focused on its role as a large US biotech, with...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/24816-main-header/1756203123218","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/24816-main-header/1756203123218"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amgn/amgen/news/is-it-too-late-to-consider-amgen-amgn-after-a-32-one-year-sh","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amgn/amgen/news/is-it-too-late-to-consider-amgen-amgn-after-a-32-one-year-sh","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0122379950.USD","LU0868494617.USD","LU0058720904.USD","DCF","BK4599","LU1023059063.AUD","BK4534","LU1983299246.USD","LU2242652126.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","LU2242646821.SGD","LU2468319806.SGD","LU0109394709.USD","LU1057294990.SGD","IE00B2B36J28.USD","BK4581","LU0889565916.HKD","BK4533","LU1571399168.USD","IE00BJT1NW94.SGD","BK4566","IE00B4R5TH58.HKD","BK4139","LU2112291526.USD","BK4588","SG9999001440.SGD","AMGN","LU0320765992.SGD","LU2089984988.USD","LU0289739699.SGD","IE0009355771.USD","IE0002141913.USD","BK4585","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628878412","title":"Amgen Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2628878412","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628878412?lang=en_us&edition=fundamental","pubTime":"2026-04-18 04:34","pubTimestamp":1776458040,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  rose 1.69% to $355.30 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 1.20% to 7,126.06 and the Dow Jones Industrial Average  rising 1.79% to 49,447.43.This was the stock's second consecutive day of gains.Amgen Inc. closed 9.20% below its 52-week high of $391.29, which the company reached on March 2nd.The stock outperformed some of its competitors Friday, as Johnson & Johnson  fell 0.15% to $234.18, Pfizer Inc.  rose 1.25% to $27.56, and AbbVie Inc.  fell 0.29% to $208.38.Trading volume  eclipsed its 50-day average volume of 2.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled April 17, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","IE00BLSP4239.USD","LU0511384066.AUD","LU1093756325.SGD","LU1196500208.SGD","LU0122379950.USD","LU1059921491.USD","IE00B19Z3B42.SGD","LU1732800096.USD","BK4550","LU2023251221.USD","LU2471134879.HKD","LU0070217475.USD","IE0002141913.USD","LU0859254822.USD","LU1585245621.USD","LU1267930573.SGD","LU2087621335.USD","LU1032466523.USD","LU0689472784.USD","LU0114720955.EUR","IE00BKVL7J92.USD","IE000M9KFDE8.USD","LU0345769128.USD","LU0738911758.USD","IE0034235303.USD","LU2430703251.USD","LU2468319806.SGD","LU1839511570.USD","LU1894683264.USD","LU1221951046.USD","LU2112291526.USD","LU1066051498.USD","LU1496350502.SGD","LU0708994859.HKD","LU2237443622.USD","04332","IE00BJJMRZ35.SGD","LU0861579265.USD","LU1934455277.USD","SG9999002224.SGD","SG9999013999.USD","BK4592","LU1121112475.USD","LU1057294990.SGD","LU0466842654.USD","LU0321505868.SGD","LU1674673428.USD","LU1778281490.HKD","IE00BLSP4452.SGD","IE00BZ1G4Q59.USD","BK4568","LU2089984988.USD","LU0306806265.USD","IE00BFTCPJ56.SGD","LU1244550221.USD","LU1221951129.SGD","LU1929549753.HKD","LU1883839398.USD","LU0256863902.USD","IE00BJT1NW94.SGD","LU0787776722.HKD","BK4585","LU1061106388.HKD","SG9999003800.SGD","AMGN","LU0889566641.SGD","BK4581","LU0545039389.USD","LU2237443895.HKD","LU2505996509.AUD","BK4532","LU0203347892.USD","LU0320765992.SGD","LU0109394709.USD","LU0792757196.USD","LU0345770308.USD","LU2242652126.USD","LU1043141396.HKD","BK4599","SG9999001440.SGD","LU1732799900.SGD","LU0203345920.USD","SG9999015945.SGD","LU0472753341.HKD","LU1430594728.SGD","LU0868494617.USD","LU2750360641.GBP","LU2750360997.AUD","LU0942090050.USD","LU1496350171.SGD","IE000SO60NU8.SGD","LU1066053197.SGD","LU0320765646.SGD","LU1244550577.SGD","IE0000B7K699.USD","LU0225771236.USD","LU1066051811.HKD","LU0640476718.USD","LU0795875086.SGD","IE0004445239.USD","LU1267930490.SGD","LU1914381329.SGD","LU0170899867.USD","LU0912757837.SGD","LU0683600562.USD","LU2471134952.CNY","LU0949170772.SGD","LU2471134796.USD","LU1571399168.USD","BK4007","LU0289739343.SGD","LU0889565916.HKD","LU2471134523.USD","SG9999011175.SGD","LU0820561909.HKD","LU2237443382.USD","LU2237443465.HKD","IE000MB6IJN5.SGD","LU0943347566.SGD","LU2129689514.USD","LU0310800379.SGD","LU0432979614.USD","LU2129689605.HKD","LU1066051225.USD","LU0965509010.AUD","LU0345769631.USD","LU1074936037.SGD","LU1894683348.USD","IE00B3T34201.USD","IE00B19Z3581.USD","LU0994945656.USD","SGXZ57979304.SGD","LU0057025933.USD","IE000BZT7R73.USD","LU0823416689.USD","IE000WAW04H5.SGD","LU0058720904.USD","LU0345770993.USD","LU2505996681.GBP","LU0211328371.USD","BK4588","IE00B2B36J28.USD","LU0225284248.USD","LU0426412945.USD","LU2237443978.SGD","BK4504","LU1291159041.SGD","IE00B4R5TH58.HKD","LU0321505439.SGD","SG9999001176.SGD","LU0158827948.USD","LU2237443549.SGD","LU1551013425.SGD","LU0234570918.USD","LU1989772923.USD","LU2347655156.SGD","IE0009355771.USD","LU1551013342.USD","IE00BVYPNW00.USD","LU1162221912.USD","LU0456855351.SGD","IE0002270589.USD","IE00B3PB1722.GBP","LU0689626769.HKD","LU1261432733.SGD","LU0069063385.USD","LU1506573853.SGD","IE000F7OJYX1.SGD","LU0820561818.USD","BK4566","IE00BN8TJ469.HKD","LU1267930813.SGD","IE00B1BXHZ80.USD","LU0124676726.USD","LU1023059063.AUD","LU1003077747.HKD","IE00BVYPNV92.GBP","LU2089284900.SGD","LU0417517546.SGD","LU1989772840.SGD","SG9999015986.USD","LU0868494708.USD","LU1934455194.USD","LU1935042991.SGD","IE00B7SZLL34.SGD","SG9999002232.USD","LU0306807586.USD","LU0553294199.USD","LU2430703178.SGD","BK4139","LU0256863811.USD","LU1093756168.USD","LU0965509101.SGD","LU0029864427.USD","LU1280957306.USD","LU2089283258.USD","LU0985481810.HKD","LU1037948541.HKD","SG9999015952.SGD","IE00BBT3K403.USD","LU0882574055.USD","LU1043141123.HKD","IE00BGHQF631.EUR","LU0795875169.SGD","LU0310799852.SGD","LU0965508806.USD","LU0289739699.SGD","BK4533","LU2592432038.USD","BK4559","LU1244550494.USD","LU1983299246.USD","LU2242646821.SGD","LU0426417589.USD","LU2129689431.USD","SG9999015978.USD","LU0985320562.USD","IE00BSNM7G36.USD","LU0289961442.SGD","LU0198837287.USD","LU0211327993.USD","LU2133065610.SGD","LU2602419157.SGD","LU1718418525.SGD","IE00B42XCP33.USD","LU0098860793.USD","LU0965509283.SGD","IE00BDGV0183.EUR","LU1037948897.HKD","LU1989771016.USD","LU2357627491.SGD","IE0001KFT4U8.USD","SG9999001176.USD","LU0661504455.SGD","LU1674673691.USD","LU0234572021.USD","LU1032955483.USD","LU2430703095.HKD","LU1934455863.HKD","LU0128525929.USD","IE00BFXG1179.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.amgen.com","stockEarnings":[{"period":"1week","weight":-0.0022},{"period":"1month","weight":0.0005},{"period":"3month","weight":0.0112},{"period":"6month","weight":0.1949},{"period":"1year","weight":0.2545},{"period":"ytd","weight":0.0651}],"compareEarnings":[{"period":"1week","weight":0.0097},{"period":"1month","weight":0.0846},{"period":"3month","weight":0.0279},{"period":"6month","weight":0.0461},{"period":"1year","weight":0.3232},{"period":"ytd","weight":0.0389}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Amgen Inc. is a biotechnology company. It discovers, develops, manufactures and delivers medicines for the toughest diseases. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve people’s lives. It operates in the human therapeutics segment. Its marketed products portfolio includes EPOGEN (epoetin alfa); Aranesp (darbepoetin alfa); Parsabiv (etelcalcetide); Neulasta (pegfilgrastim); KANJINTI (trastuzumab-anns); Otezla; BLINCYTO (blinatumomab); ACTIMMUNE (interferon gamma-1b); Neulasta (pegfilgrastim); Sensipar/Mimpara (cinacalcet); Prolia (denosumab); ENBREL; QUINSAIR (levofloxacin); Repatha (evolocumab) and others. It markets ENBREL, a tumor necrosis factor blocker, in the United States and Canada. It markets Otezla, a small molecule that inhibits phosphodiesterase 4, in many countries around the world. It markets Repatha, a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, in many countries around the world.","yearOnYearQuotes":[{"month":1,"riseRate":0.651163,"avgChangeRate":0.034336},{"month":2,"riseRate":0.488372,"avgChangeRate":0.00202},{"month":3,"riseRate":0.511628,"avgChangeRate":0.016602},{"month":4,"riseRate":0.44186,"avgChangeRate":-0.002999},{"month":5,"riseRate":0.52381,"avgChangeRate":0.024179},{"month":6,"riseRate":0.5,"avgChangeRate":0.003875},{"month":7,"riseRate":0.767442,"avgChangeRate":0.052562},{"month":8,"riseRate":0.604651,"avgChangeRate":0.004451},{"month":9,"riseRate":0.511628,"avgChangeRate":0.002296},{"month":10,"riseRate":0.534884,"avgChangeRate":0.021538},{"month":11,"riseRate":0.627907,"avgChangeRate":0.022348},{"month":12,"riseRate":0.627907,"avgChangeRate":0.045446}],"exchange":"NASDAQ","name":"Amgen","nameEN":"Amgen"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Amgen(AMGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Amgen(AMGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Amgen,AMGN,Amgen股票,Amgen股票老虎,Amgen股票老虎国际,Amgen行情,Amgen股票行情,Amgen股价,Amgen股市,Amgen股票价格,Amgen股票交易,Amgen股票购买,Amgen股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Amgen(AMGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Amgen(AMGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}